The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PROs) from the phase III IMspire150 trial of atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in patients (pts) with BRAFV600+melanoma.
 
Karl D. Lewis
Honoraria - Array BioPharma
Consulting or Advisory Role - Array BioPharma; Merck; Regeneron; Roche
Research Funding - alkermes (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Kartos Therapeutics (Inst); Merck (Inst); Nektar (Inst); Neon Therapeutics (Inst); OncoSec (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - alkermes; Merck; Neon Therapeutics; Regeneron; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Regeneron; Roche/Genentech
 
Caroline Robert
Consulting or Advisory Role - Amgen; Biothera; Bristol-Myers Squibb; CureVac; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Immunocore; Incyte; Italfarmaco; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sandoz; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Helen Gogas
Honoraria - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb; MSD Oncology; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Roche
 
Svetlana Protsenko
No Relationships to Disclose
 
Rodrigo Perez Pereira
Honoraria - Bristol-Myers Squibb; Roche
Research Funding - Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
 
Thomas K. Eigentler
Consulting or Advisory Role - Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Pierre Fabre; Roche Pharma AG; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Lev V. Demidov
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Expert Testimony - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Georgy Moiseevich Manikhas
No Relationships to Disclose
 
Sara Tadesse-Bell
Employment - Genentech/Roche; Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Kuan-Chieh Huang
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech
 
V. McNally
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Sohail Mulla
Employment - F. Hoffmann LaRoche
 
Grant A. McArthur
Research Funding - Genentech (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); MSD (Inst); Roche (Inst)
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Incyte; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche; Sun Pharma